126 related articles for article (PubMed ID: 10428424)
1. Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action.
Scorza C; Silveira R; Nichols DE; Reyes-Parada M
Neuropharmacology; 1999 Jul; 38(7):1055-61. PubMed ID: 10428424
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).
Li Q; Murakami I; Stall S; Levy AD; Brownfield MS; Nichols DE; Van de Kar LD
J Pharmacol Exp Ther; 1996 Dec; 279(3):1261-7. PubMed ID: 8968349
[TBL] [Abstract][Full Text] [Related]
3. Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
Marona-Lewicka D; Nichols DE
Psychopharmacology (Berl); 1998 Jul; 138(1):67-75. PubMed ID: 9694528
[TBL] [Abstract][Full Text] [Related]
4. Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.
Marona-Lewicka D; Nichols DE
Eur J Pharmacol; 1994 Jun; 258(1-2):1-13. PubMed ID: 7925587
[TBL] [Abstract][Full Text] [Related]
5. p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent.
Huang X; Marona-Lewicka D; Nichols DE
Eur J Pharmacol; 1992 Dec; 229(1):31-8. PubMed ID: 1473561
[TBL] [Abstract][Full Text] [Related]
6. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
[TBL] [Abstract][Full Text] [Related]
7. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors.
Hjorth S; Auerbach SB
Eur J Pharmacol; 1994 Aug; 260(2-3):251-5. PubMed ID: 7988652
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
[TBL] [Abstract][Full Text] [Related]
9. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
Li XM; Perry KW; Wong DT
Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599
[TBL] [Abstract][Full Text] [Related]
10. 5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.
Huang X; Nichols DE
Eur J Pharmacol; 1993 Jul; 238(2-3):291-6. PubMed ID: 8104811
[TBL] [Abstract][Full Text] [Related]
11. Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study.
Malagié I; Trillat AC; Douvier E; Anmella MC; Dessalles MC; Jacquot C; Gardier AM
Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec; 354(6):785-90. PubMed ID: 8971740
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin.
Okada M; Kawata Y; Murakami T; Wada K; Mizuno K; Kondo T; Kaneko S
Eur J Neurosci; 1999 Jan; 11(1):1-9. PubMed ID: 9987006
[TBL] [Abstract][Full Text] [Related]
13. Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release.
Callaway CW; Wing LL; Nichols DE; Geyer MA
Psychopharmacology (Berl); 1993; 111(2):169-78. PubMed ID: 7870948
[TBL] [Abstract][Full Text] [Related]
14. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.
Matzen L; van Amsterdam C; Rautenberg W; Greiner HE; Harting J; Seyfried CA; Böttcher H
J Med Chem; 2000 Mar; 43(6):1149-57. PubMed ID: 10737747
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis.
Boothman LJ; Mitchell SN; Sharp T
Neuropharmacology; 2006 May; 50(6):726-32. PubMed ID: 16434063
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
Beyer CE; Boikess S; Luo B; Dawson LA
J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
[TBL] [Abstract][Full Text] [Related]
17. The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain.
Romero L; Hervás I; Artigas F
Neurosci Lett; 1996 Nov; 219(2):123-6. PubMed ID: 8971795
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
Dawson LA; Li P
J Neural Transm (Vienna); 2003 Jun; 110(6):577-90. PubMed ID: 12768354
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
Barton CL; Hutson PH
Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
[TBL] [Abstract][Full Text] [Related]
20. Sustained administration of trazodone enhances serotonergic neurotransmission: in vivo electrophysiological study in the rat brain.
Ghanbari R; El Mansari M; Blier P
J Pharmacol Exp Ther; 2010 Oct; 335(1):197-206. PubMed ID: 20647493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
